Cargando…
Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides
[Image: see text] Telomerase represents an attractive target in oncology as it is expressed in cancer but not in normal tissues. The oligonucleotide inhibitors of telomerase represent a promising anticancer strategy, although poor cellular uptake can restrict their efficacy. In this study, gold nano...
Autores principales: | Bavelaar, Bas M., Song, Lei, Jackson, Mark R., Able, Sarah, Tietz, Ole, Skaripa-Koukelli, Irini, Waghorn, Philip A., Gill, Martin R., Carlisle, Robert C., Tarsounas, Madalena, Vallis, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493550/ https://www.ncbi.nlm.nih.gov/pubmed/34449222 http://dx.doi.org/10.1021/acs.molpharmaceut.1c00442 |
Ejemplares similares
-
Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018) -
(111)In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
por: Gill, Martin R., et al.
Publicado: (2018) -
Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
por: Thomas, Eloise, et al.
Publicado: (2019) -
3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
por: Skaripa-Koukelli, Irini, et al.
Publicado: (2021) -
Targeting telomerase with radiolabeled inhibitors
por: Waghorn, Philip A., et al.
Publicado: (2017)